journal article·2026-04-24Open access

A Multifunctional Electrospun Hemostatic Sponge for Effective Wound Closure and Healing

Bo Zhou, Boxiang Zhang, Guanghui Gao, Xiuyan Ren, Cosimo Ligorio, Lijie Duan

ACS Applied Polymer Materials· Volume 8· Issue 8

Abstract

Uncontrolled hemorrhage following severe trauma necessitates hemostatic agents capable of not only instantaneous clotting but also pro-healing functionality. To bridge this gap, we engineered a dual-release fibrous sponge (ULOCa-T) via an integrated electrospinning-electrospraying strategy. This design synergistically leverages surface-immobilized thrombin for immediate hemostatic activation and sequentially released calcium chloride (CaCl 2 ) from a hygroscopic thermoplastic polyurethane (TPU)/polycaprolactone (PCL)/hydrophilic poly(ethylene oxide) (PEO) matrix to amplify the coagulation cascade. In a rat liver injury model, ULOCa-T achieved effective hemostasis within 157 s─a 57% reduction compared to controls─and drastically cut blood loss to 48.16 mg. Beyond its superabsorbent capacity (12× its dry weight), the sponge demonstrated multifaceted bioactivity: it promoted platelet activation, downregulated key pro-inflammatory cytokines (IL-1β and TNF-α), and enhanced the expression of regeneration markers (VEGF and CD31), collectively accelerating wound closure. Owing to its straightforward fabrication and ready-to-use nature, ULOCa-T presents a transformative potential for managing trauma and surgical bleeding.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemostasis and retained surgical items · Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Polymeric and Soft Materials Laboratory, School of Chemistry and Life Science, Advanced Institute of Materials Science

Changchun University of Technology

The Second Hospital of Jilin University

Advanced Institute of Materials Science, School of Chemical Engineering

Biodiscovery Institute

University of Nottingham

Department of Chemical and Environmental Engineering and School of Pharmacy

Funding

AO Foundation · Department of Science and Technology of Jilin Province · China Scholarship Council

References (54)

Show source-provided references
1. 10.1002/adma.20170085910.1002/adma.201700859 ↗
2. 10.1039/D2SC04962G10.1039/D2SC04962G ↗
3. 10.1016/j.bioactmat.2020.05.00810.1016/j.bioactmat.2020.05.008 ↗
4. 10.1038/s41570-021-00323-z10.1038/s41570-021-00323-z ↗
5. 10.1016/j.bioactmat.2023.01.01910.1016/j.bioactmat.2023.01.019 ↗
6. 10.1021/acsami.9b1773210.1021/acsami.9b17732 ↗
7. 10.1002/adfm.20221134010.1002/adfm.202211340 ↗
8. 10.1002/adhm.20210091810.1002/adhm.202100918 ↗
9. 10.1002/adma.20230184910.1002/adma.202301849 ↗
10. 10.3390/pharmaceutics1504114410.3390/pharmaceutics15041144 ↗
11. 10.1186/s12951-023-01987-z10.1186/s12951-023-01987-z ↗
12. 10.1016/j.jconrel.2020.07.03810.1016/j.jconrel.2020.07.038 ↗
13. 10.1038/s41467-019-13512-810.1038/s41467-019-13512-8 ↗
14. 10.1016/j.ijbiomac.2022.07.18610.1016/j.ijbiomac.2022.07.186 ↗
15. 10.1007/s10570-020-03479-x10.1007/s10570-020-03479-x ↗
16. 10.2147/IJN.S7255310.2147/IJN.S72553 ↗
17. 10.1016/j.carbpol.2018.12.05610.1016/j.carbpol.2018.12.056 ↗
18. 10.1039/C9NR01477B10.1039/C9NR01477B ↗
19. 10.1021/acsami.9b1244410.1021/acsami.9b12444 ↗
20. 10.3390/pharmaceutics1312212710.3390/pharmaceutics13122127 ↗
21. 10.1002/adhm.20230346010.1002/adhm.202303460 ↗
22. 10.1007/s10853-023-09124-910.1007/s10853-023-09124-9 ↗
23. 10.1097/shk.000000000000064610.1097/shk.0000000000000646 ↗
24. Iso, I. 10993–5:2009 Biological Evaluation of Medical Devices─Part 5: Tests for in Vitro Cytotoxicity ; International Organization for Standardization: Geneva, 2009; 34.
25. 10.1007/s00240-024-01556-510.1007/s00240-024-01556-5 ↗
26. 10.1002/adhm.20230220910.1002/adhm.202302209 ↗
27. 10.1016/j.carbpol.2019.11500710.1016/j.carbpol.2019.115007 ↗
28. 10.1039/D3TB01900D10.1039/D3TB01900D ↗
29. 10.1016/j.ijbiomac.2021.02.16210.1016/j.ijbiomac.2021.02.162 ↗
30. 10.3390/ma1315325010.3390/ma13153250 ↗
31. 10.1016/j.ijbiomac.2023.12664210.1016/j.ijbiomac.2023.126642 ↗
32. 10.1016/j.ijbiomac.2023.12400410.1016/j.ijbiomac.2023.124004 ↗
33. 10.1021/acssuschemeng.6b0284910.1021/acssuschemeng.6b02849 ↗
34. 10.1016/j.thromres.2020.07.02710.1016/j.thromres.2020.07.027 ↗
35. 10.1039/D1MA00137J10.1039/D1MA00137J ↗
36. 10.1021/acsami.9b0879910.1021/acsami.9b08799 ↗
37. 10.1126/scitranslmed.301038310.1126/scitranslmed.3010383 ↗
38. 10.4103/0019-5049.14464310.4103/0019-5049.144643 ↗
39. 10.1002/adfm.20191074810.1002/adfm.201910748 ↗
40. 10.1039/C9SM01296F10.1039/C9SM01296F ↗
41. 10.1016/j.carbpol.2017.08.07010.1016/j.carbpol.2017.08.070 ↗
42. 10.1111/j.1538-7836.2007.02500.x10.1111/j.1538-7836.2007.02500.x ↗
43. 10.1016/j.nantod.2021.10116510.1016/j.nantod.2021.101165 ↗
44. 10.2174/138920102337828310.2174/1389201023378283 ↗
45. 10.1016/j.cej.2024.15054510.1016/j.cej.2024.150545 ↗
46. 10.2174/09298670978987821010.2174/092986709789878210 ↗
47. Singh D. · Cardiol Cardiovasc Med. · 2023 · 7 · 510.26502/fccm.92920302 ↗
48. 10.4049/jimmunol.163.7.396310.4049/jimmunol.163.7.3963 ↗
49. 10.1073/pnas.150962711210.1073/pnas.1509627112 ↗
50. DeLisser H. M. · Am. J. Pathol. · 1997 · 151 · 671
51. 10.1016/j.surg.2005.07.01010.1016/j.surg.2005.07.010 ↗
52. 10.1039/D2BM01767A10.1039/D2BM01767A ↗
53. 10.1016/j.eurpolymj.2021.11073310.1016/j.eurpolymj.2021.110733 ↗
54. 10.1039/C9TB00659A10.1039/C9TB00659A ↗